Google Messages is splitting Gallery and Camera into separate options
TL;DR Google Messages is separating Gallery and Camera in the latest beta.
Both options now have their own dedicated buttons.
Tapping on Camera still brings up the camera with the gallery below.
Google is making a change to the Messages app in the latest beta. The change should make accessing your gallery or camera a little more intuitive.
When you go into Google Messages and tap on the plus icon in the text field, you'll see a group of options like GIFs, Files, Location, and more. You'll also see an entry for Gallery, which doubles as an access point for your gallery and camera. On Reddit, a Google Messages beta user noticed this option has now changed.
Old
New
In the beta, Google has separated the camera from the gallery. Now there is a new Camera option sitting in the menu. According to the user, if you tap on Gallery, it will only give you access to your gallery. Meanwhile, tapping on the Camera button brings up the old setup with the camera up top and the gallery below it.
What do you think of this change? Let us know in the comments section below.
Got a tip? Talk to us! Email our staff at
Email our staff at news@androidauthority.com . You can stay anonymous or get credit for the info, it's your choice.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Abbott Laboratories (ABT) Drops on Lower Full-Year Guidance
We recently published . Abbott Laboratories (NYSE:ABT) is one of the worst-performing companies on Thursday. Abbott Laboratories declined by 8.52 percent on Thursday to end at $120.51 apiece as investors were disheartened by the lowering of its full-year guidance. For the full year, Abbott Laboratories (NYSE:ABT) now projects organic sales growth, excluding COVID-19 testing-related sales, to grow between 7.5 to 8 percent, or 6 to 7 percent when including COVID-19 testing-related sales. Adjusted diluted earnings per share were pegged at $5.1 to $5.2 for the full year, while adjusted diluted EPS were expected to settle at $1.28 to $1.32 for the third quarter of the year. In an interview on CNBC, Abbott Laboratories (NYSE:ABT) CEO Robert Ford deemed the drop an 'overreaction.' 'I think this is a little bit of an overreaction. Of course, we are all over this,' Ford said. 'We're focused on this, but the fundamentals of the entire rest of the company are pretty much intact, and this is just really a point in time that we have to get through.' An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. In the second quarter of the year, Abbott Laboratories (NYSE:ABT) grew its net income by 36.7 percent to $1.779 billion from $1.3 billion in the same period last year. Net sales increased by 7.4 percent to $11.142 billion from $10.377 billion year-on-year. While we acknowledge the potential of ABT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
6 minutes ago
- Yahoo
Netflix stock slips despite Q2 beat: How valuation factors in
Netflix (NFLX) stock is under pressure despite its second quarter earnings beat. Yahoo Finance Senior Reporter Allie Canal and Washington Crossing Advisors senior portfolio manager Chad Morganlander join Opening Bid with Executive Editor Brian Sozzi to take a closer look at what's driving the stock lower, despite the strong results, and what it could signal about upcoming Big Tech earnings amid valuation concerns. To watch more expert insights and analysis on the latest market action, check out more Opening Bid here. Ali stock selling off on this news. Um, but look, you go into the fundamentals of Netflix. They hit everything that I want to see as a former stock analyst. Margins up, revenue growth accelerated quarter over quarter, outlook raised, they got a new giant content slate coming out in the second half of the year. Not only live experiences, what with the double header on Christmas Day, you have Happy Gilmore 2 dropping. That's exciting. I don't know what else Netflix could have did yesterday. Yeah, and if you look through all the analyst notes, it's what I've been doing all morning. Everyone is still pretty bullish, but they did say that it's really hard as a company to surpass elevated expectations. Earlier, I was talking about the valuation, 40 times forward earnings. The stock is up over 40% since the start of the year. So perhaps they wanted that full year guidance to come in a little more ahead of where we're at, considering where the stock is trading right now and all those catalysts still to come, like you were just mentioning, Brian. But by and large, this is a company that has a solid balance sheet. It even has some AI touch points. They are going to be using generative AI in their shows. And as we know, any company that has those AI adjacent business propositions, that's going to be rewarded by investors. So there just seems to be a lot of growth drivers here. Advertising, in particular, has been one that's stuck out. It's one of the cheapest ad plans on the market. They're continuing to see solid growth there, and they are expected to double their revenue by the end of this year to around 3 billion, and a lot of analysts and sources who I speak with say that now subscriber numbers are no longer available, to focus on those ad numbers because that's an area where we're going to consistently see a lot of top-line growth. So that's, that's really strong. We have the content side of the equation that's really strong, a really solid back half of the year, and like you said, nothing really disappointed me in this report either. But when you're dealing with investors that just have a high bar, sometimes, even that struggles on the stock price side of things. Uh, so I'm going to sum up what Ali just said, Chad. Netflix is a fundamental beast. Now, having said that, this reaction that we're seeing in the market to these very strong earnings and outlook, any read, any read through there to large cap tech earnings that are going to come over the next two weeks. Microsoft, bioindications are probably going to come out here, good quarter, beat, relatively upbeat earnings call. Is the risk here, we got to sell off there too? Well, I mean, all these tech names, uh, on the MAG 7 side have been moving higher in anticipation of a really white hot earnings, uh, top line revenue growth, and whatnot. Uh, so, yes, you can get a breather where there is some consolidation within the market overall. But again, you know, there's a lot of tailwind here when it comes to the AI related companies, revenue growth. This is real revenue growth, real earnings coming through. Uh, so, over the long run, if that you have that, then you should see higher highs within these names. Related Videos US Consumer Sentiment Rises to a Five-Month High Chevron's $53 billion Hess deal finally approved: What to know Talen Energy, 3M outlook, SLB earnings: Trending Tickers Waller calls for rate cut, GENIUS Act, Netflix earnings: 3 Things Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
CoreWeave (CRWV) Drops as HSBC Turns Bearish
We recently published . CoreWeave, Inc. (NASDAQ:CRWV) is one of the worst-performing companies on Thursday. CoreWeave dropped by 7.57 percent on Thursday to close at $132.21 apiece as investors disposed of shares following an investment firm's pessimistic outlook for the company. In a market note, CoreWeave, Inc. (NASDAQ:CRWV) earned a 'reduce' rating and a meager $32 price target from HSBC Global Research, marking a 76-percent downside from its latest closing price. According to HSBC, the rating revision was based on CoreWeave, Inc.'s (NASDAQ:CRWV) overreliance on Microsoft (NASDAQ:MSFT) and Nvidia (NASDAQ:NVDA). However, it noted that such clients have not adopted CoreWeave, Inc.'s (NASDAQ:CRWV) software services, weakening the company's competitiveness and customer stickiness. 'Selling more value-added services driven by the software stack, as is done by general-purpose clouds, may be key to achieving stronger returns,' the market note said. A close-up of a businesswoman using a laptop, being illuminated by the AI-enabled cloud interface sponsored by the company. 'But CoreWeave would first need to successfully shift to a general-purpose cloud offering and diversify away from Microsoft and Open AI (which together accounted for more than 72% of its revenue and most of its backlog in 1Q25) towards customers that require CoreWeave's full software stack.' While we acknowledge the potential of CRWV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
